Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Algae-C logo — Our technology enables the production of high-value plant-ba...

Algae-C

Our technology enables the production of high-value plant-based active pharmaceutical ingredients using designer algae.

Founded 2015 Canada Ontario, Canada 3 employees Total: $300.00K Biopharma, Biotechnology

General Information

Company Name Algae-C
Founded Year 2015
Location Canada Ontario, Canada
Employees 3
Industries Biopharma, Biotechnology
Business Model B2B, B2B2B, D2C
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Algae-C. To contact Algae-C, visit algae-c.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Algae-C compare?

A PDF of Algae-C and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Algae-C soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Algae-C

Algae-C, founded in 2015, is a pioneering player in the biopharma and biotechnology industries. The company is headquartered in Canada and is gaining attention for its innovative approach to producing high-value, plant-based active pharmaceutical ingredients (APIs) through the use of designer algae. This unique technology aligns with the industry's shift towards sustainable and efficient bio-production methods.

The company's slogan, "Our technology enables the production of high-value plant-based active pharmaceutical ingredients using designer algae," highlights its commitment to disrupting traditional API production with greener, cost-effective solutions.

In its most recent financing, Algae-C secured €300.00K in a funding round on 07 December 2022, with investment from Katapult. This injection of capital is expected to bolster their R&D and commercialization efforts, positioning them for further growth and technological advancements.

Business keywords: algae technology, pharmaceutical, nutraceutical, therapeutic, plant-based, active pharmaceutical ingredients, designer algae, partnerships, industry collaboration

Services & Products

Strain Discovery and Development
Process and Manufacturing Optimization
Quality and Analytical Validation
Contract Manufacturing
Scientific Research and Development

Target Customers

Pharmaceutical Companies Consumer Health Organizations Nutraceutical Firms Research Institutions Ingredient Suppliers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Funding Round Algae €300.00K 1
Katapult
07 Dec 2022
Series A Algae Undisclosed 1
Katapult Ocean
Katapult Ocean
12 Jul 2022

Algae-C Alternatives & Competitors

View All Alternatives
Algae-C vs
Overseed
Overseed France

Medical cannabis: from seed to purified pharmaceutical grade active ingredients

Series A
23 employees
Biopharma, Biotechnology
Algae-C vs
Concept Matrix Solutions, Inc.
Concept Matrix Solutions, Inc. United States

R&D of therapeutic consumer and medical products. 🌱 Helping new and existing brands from concept to...

Corporate Round
6 employees
Biopharma, Biotechnology
Algae-C vs
ProBio
ProBio United States

Manufacturing Life-Changing Therapies

Series C
246 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Algae-C

Our technology enables the production of high-value plant-based active pharmaceutical ingredients using designer algae.
Algae-C was founded in 2015.
Algae-C is headquartered in Ontario, Canada.
Algae-C operates in Biopharma and Biotechnology. Its work centres on algae technology, pharmaceutical, nutraceutical and therapeutic. Its customers include Pharmaceutical Companies, Consumer Health Organizations and Nutraceutical Firms.
Algae-C has a B2B, B2B2B and D2C business model. Its revenue comes from Licensing, Product Sales and Service Fee.
Algae-C has approximately 3 employees.
Algae-C has completed 2 funding rounds, raising a total of $300.00K.
Algae-C offers: Strain Discovery and Development, Process and Manufacturing Optimization, Quality and Analytical Validation, Contract Manufacturing, Scientific Research and Development.
Top alternatives and competitors to Algae-C include Overseed, Concept Matrix Solutions, Inc., ProBio, Protillion Biosciences, Iksuda Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Algae-C and Overseed are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Algae-C, https://bouncewatch.com/company/algae-c, updated 18 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes